These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15991039)

  • 1. Communication of findings in pharmacovigilance: use of the term "signal" and the need for precision in its use.
    Hauben M; Reich L
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):479-80. PubMed ID: 15991039
    [No Abstract]   [Full Text] [Related]  

  • 2. Harmonisation in pharmacovigilance.
    Edwards IR; Biriell C
    Drug Saf; 1994 Feb; 10(2):93-102. PubMed ID: 8011183
    [No Abstract]   [Full Text] [Related]  

  • 3. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems.
    Pal SN; Duncombe C; Falzon D; Olsson S
    Drug Saf; 2013 Feb; 36(2):75-81. PubMed ID: 23329541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying signals of interest when screening for drug-outcome associations in health care data.
    Pottegård A; Hallas J; Wang SV; Gagne JJ
    Br J Clin Pharmacol; 2018 Sep; 84(9):1865-1867. PubMed ID: 29862551
    [No Abstract]   [Full Text] [Related]  

  • 5. The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance.
    Osborne V; Shakir SAW
    Drug Saf; 2018 Jan; 41(1):139-141. PubMed ID: 28795368
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of the "French Levothyrox crisis" on signal detection in the World Health Organization pharmacovigilance database.
    Khouri C; Revol B; Lepelley M; Mallaret M; Cracowski JL
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1427-1428. PubMed ID: 30379373
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug safety: from development to clinical use].
    Ovchinnikova EA; Gerasimov VB
    Antibiot Khimioter; 2006; 51(6):15-22. PubMed ID: 17523417
    [No Abstract]   [Full Text] [Related]  

  • 8. Signal selection and follow-up in pharmacovigilance.
    Meyboom RH; Lindquist M; Egberts AC; Edwards IR
    Drug Saf; 2002; 25(6):459-65. PubMed ID: 12071784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of Pharmacovigilance Centres in medication errors detection: a questionnaire-based analysis.
    Benabdallah G; Benkirane R; Khattabi A; Edwards IR; Bencheikh RS
    Int J Risk Saf Med; 2011; 23(1):17-29. PubMed ID: 21507783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Direct reporting by patients of adverse drug reactions in Spain].
    Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
    Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting adverse drug reaction reporting: comparison of different approaches.
    Ribeiro-Vaz I; Santos CC; Cruz-Correia R
    Rev Saude Publica; 2016; 50():14. PubMed ID: 27143614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacovigilance of medicinal products in Poland--new guidelines].
    Jabłecka A; Korzeniowska K; Balcer-Dymel N
    Przegl Lek; 2012; 69(10):1127-8. PubMed ID: 23421106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations from the Thirty-seventh Annual Meeting of National Pharmacovigilance Centres.
    Int J Risk Saf Med; 2015; 27(3):143-52. PubMed ID: 26410248
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reaction reporting and pharmacovigilance of new therapeutic agents.
    Haas SJ
    South Med J; 2006 Apr; 99(4):325-6. PubMed ID: 16634234
    [No Abstract]   [Full Text] [Related]  

  • 16. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
    Schäublin M
    Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern methods of pharmacovigilance: detecting adverse effects of drugs.
    Norén GN; Edwards IR
    Clin Med (Lond); 2009 Oct; 9(5):486-9. PubMed ID: 19886114
    [No Abstract]   [Full Text] [Related]  

  • 19. Notification about allergic drug reactions.
    Danish M; Pires AW
    Am J Health Syst Pharm; 1995 Jul; 52(13):1466. PubMed ID: 7671049
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.